secwatch.observer — SEC 8-K summary
======================================

Issuer:     EVOME MEDICAL TECHNOLOGIES INC. (—)
CIK:        0001617765
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001062993-23-016209
Event type: debt
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.04, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Salona Global restructures Biodex debt: cash sweep, 12% interest, forbearance until July 2025
--------------------------------------------------------------------------------

- Total outstanding debt $8.26M ($6.76M acquisition debt + $1.5M working capital loan) as of July 25, 2023.
- Forbearance agreement prevents acceleration until July 31, 2025; past due amounts accrue 12% interest.
- Company must pay all cash over $2.5M monthly, 50% of any capital raised, and obtain consent for capex >$100k.
- Working capital loan due Oct 31, 2023; acquisition debt due July 31, 2025.
- Company pursuing $2M ABL facility on Biodex assets to pay down working capital loan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617765/000106299323016209/0001062993-23-016209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617765/000106299323016209/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-23-016209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer